Two Sigma Securities’s Citius Pharmaceuticals CTXR Stock Holding History

Two Sigma Securities’s Portfolio CTXR Stock Details CTXR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.05K	Buy	+10,006	New	+$6.77K	﹤0.01%	1586
2026 Q1	–	Sell	-28,578	Closed	-$22.2K	–	1744
2025 Q4	$22.2K	Buy	+28,578	New	+$35.7K	﹤0.01%	1164
2024 Q1	–	Sell	-1,262	Closed	-$23.9K	–	3072
2023 Q4	$23.9K	Buy	1,262 +801	+174%	+$15.2K	﹤0.01%	2695
2023 Q3	$7.88K	Sell	461 -105	-19%	-$2.5K	﹤0.01%	2735
2023 Q2	$17K	Buy	+566	New	+$18.6K	﹤0.01%	2531
2023 Q1	–	Sell	-2,465	Closed	-$48.7K	–	2770
2022 Q4	$48.7K	Buy	2,465 +603	+32%	+$16.5K	﹤0.01%	2167
2022 Q3	$56K	Buy	+1,862	New	+$51.2K	﹤0.01%	2173
2021 Q1	–	Sell	-822	Closed	-$21K	–	1013
2020 Q4	$21K	Buy	+822	New	+$21.4K	﹤0.01%	1601
2020 Q3	–	Sell	-418	Closed	-$12K	–	1358
2020 Q2	$12K	Buy	+418	New	+$9.14K	﹤0.01%	1306

Other funds holding CTXR

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

MFS

Miller Financial Services Marshall, Michigan $124M AUM 17.62% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return

AAG

Asset Advisory Group Kinnelon, New Jersey $229M AUM

Two Sigma Securities's CTXR Position: Q2 2026 in Review

Two Sigma Securities opened a new position in Citius Pharmaceuticals (CTXR) in Q2 2026: 10,006 shares worth $6.05K. The stake represents ﹤0.01% of the portfolio and ranks #1586 among its holdings. This is a return to the name: Two Sigma Securities previously reported a position in CTXR as recently as Q4 2025.

Two Sigma Securities first reported a position in CTXR in Q2 2020 and has held it in 9 quarters since. The position peaked at $56K in Q3 2022. 43 funds tracked by Wall St. Rank hold CTXR as of Q2 2026.

Two Sigma Securities held 10,006 shares of Citius Pharmaceuticals worth $6.05K as of Q2 2026.
Citius Pharmaceuticals was a new Two Sigma Securities position in Q2 2026.
Citius Pharmaceuticals made up ﹤0.01% of Two Sigma Securities's portfolio in Q2 2026, its #1586 holding.
Two Sigma Securities first reported a position in Citius Pharmaceuticals in Q2 2020 and has held it in 9 quarters since.
Two Sigma Securities's Citius Pharmaceuticals position peaked at $56K in Q3 2022.
43 funds tracked by Wall St. Rank held Citius Pharmaceuticals as of Q2 2026.

Based on Two Sigma Securities's 13F filing for Q2 2026, filed 14 Aug 2026.